U.S. markets closed
  • S&P Futures

    4,356.25
    +8.00 (+0.18%)
     
  • Dow Futures

    33,966.00
    +127.00 (+0.38%)
     
  • Nasdaq Futures

    15,023.75
    +14.25 (+0.09%)
     
  • Russell 2000 Futures

    2,182.00
    +5.20 (+0.24%)
     
  • Crude Oil

    70.74
    +0.45 (+0.64%)
     
  • Gold

    1,764.40
    +0.60 (+0.03%)
     
  • Silver

    22.27
    +0.07 (+0.30%)
     
  • EUR/USD

    1.1736
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    1.3090
    -0.0610 (-4.45%)
     
  • Vix

    25.71
    +4.90 (+23.55%)
     
  • GBP/USD

    1.3667
    +0.0007 (+0.05%)
     
  • USD/JPY

    109.5420
    +0.1220 (+0.11%)
     
  • BTC-USD

    42,542.86
    -4,592.47 (-9.74%)
     
  • CMC Crypto 200

    1,064.27
    -70.11 (-6.18%)
     
  • FTSE 100

    6,903.91
    -59.73 (-0.86%)
     
  • Nikkei 225

    29,924.83
    -575.22 (-1.89%)
     

MindMed Interim CEO on the growing competition in psychedelics industry

In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Robert Barrow, MindMed Interim CEO, joins Yahoo Finance to discuss then transition in MindMed’s CEO, future outlook for the company and the psychedelics industry.